Substance P promotes susceptibility to pseudomonas aeruginosa keratitis in resistant mice: Anti-inflammatory mediators downregulated

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 4, 2008, Pages 1502-1511

  McClellan, Sharon A ^a   Zhang, Yunfan ^a   Barrett, Ronald P ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE ANTIBODY; AUTACOID; CYTOKINE; DRUG DERIVATIVE; MESSENGER RNA; SPANTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CELL INFILTRATION; CONTROLLED STUDY; CORNEA PERFORATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DOWN REGULATION; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATITIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SLIT LAMP; TH1 CELL; THROMBOCYTE COUNT; ANIMAL; BACTERIAL EYE INFECTION; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CONFOCAL MICROSCOPY; CORNEA ULCER; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GRAM NEGATIVE INFECTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NATURAL KILLER CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CORNEAL ULCER; CYTOKINES; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, BACTERIAL; FEMALE; INFLAMMATION MEDIATORS; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NEUTROPHILS; NF-KAPPA B; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE P; TH1 CELLS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 45549090763     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1369     Document Type: Article

References (44)

1. Wilhelmus KR. Bacterial keratitis. In: Pepose JS, Holland GN, Wil-helmus KR, eds. Ocular Infection and Immunity. St. Louis, MO: Mosby; 1995:970-1031.
2. Rattanatam T, Heng WJ, Rapuano CJ, Laibson PR, Cohen EJ. Trends in contact lens-related corneal ulcers. Cornea. 2001;20:290-294.
3. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23:1-30.
4. Hazlett LD, McClellan S, Kwon B, Barrett R. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest Ophthalmol Vis Sci. 2000;41:805-810.
5. Rudner XL, Kernacki KA, Barrett RP, Hazlett LD. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates MIP-2 production, PMN persistence and corneal perforation. J Immunol. 2000;164:6576-6582.
6. Hazlett LD, Rudner XL, McClellan SA, Barrett RP, Lighvani S. IL-12 and IFN-7 in Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 2002;43:419-424.
7. Kernacki KA, Barrett RP, Hobden JA, Hazlett LD. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection. J Immunol. 2000;164: 1037-1045.
8. Huang X, McClellan SA, Barrett RP, Hazlett LD. IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-7 production. J Immunol. 2002;168: 5756-5763.
9. McClellan SA, Huang X, Barrett RP, vanRooijen N, Hazlett LD. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro-and antiinflammatory cytokines in BALB/c mice. J Immunol. 2003;170: 5219-5227.
10. Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Lighvani S. spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2007;48:797-807.
11. Vishwanath R, Mukherjee R. Substance P promotes lymphocyte- endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. J Neuroimmunol. 1996;71:163-171.
12. Quinlan KL, Naik SM, Cannon G, et al. Substance P activates coincident NF-AT-and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intra- cellular calcium mobilization. JImmunol. 1999;163:5656-5665.
13. O'Connor TM, O,Connel J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201:167-180.
14. Lighvani S, Huang X, Trivedi PP, Swanborg RH, Hazlett LD. Substance P regulates natural killer cell interferon-γ production and resistance to Pseudomonas aeruginosa infection. Eur J Immu- nol. 2005;35:1567-1575.
15. Szliter EA, Lighvani S, Barrett RP, Hazlett LD. Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. J Immunol. 2007;178:1105-1114.
16. + T cell-dependent kera- titis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1997;159:6283-6290.
17. Hazlett LD, Moon MM, Strejc M, Berk RS. Evidence for N-acetyl- mannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci. 1987;28:1978-1985.
18. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
19. Williams RN, Patterson CA, Eakins KE. Quantitation of ocular inflammation: evaluation of polymorphonuclear leukocyte inflammation by measuring myeloperoxidase activity. Curr Eye Res. 1983;2:465-470.
20. Bohnet SG, Traynor TR, Majde JA, Kacsoh B, Krueger JM. Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin, and 2′5′-oligoad- enylate synthetase expression. Brain Res. 2004;1027:117-125.
21. Muller LJ, Marfurt CF, Cruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76:421-542.
22. Kennedy PG, Rodgers J, Bradley B, et al. Clinical and neuroinflam- matory responses to meningoencephalitis in substance P receptor knockout mice. Brain. 2003;126:1683-1690.
23. Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ. SP recognition by a subset of human T lymphocytes. JClin Invest. 1984; 74:1532-1539.
24. Stanisz AM, Scicchitano R, Dazin P, Bienenstock J, Payan DG. Distribution of SP receptors on murine spleen and Peyer,s patch T and B cells. J Immunol. 1987;139:749-754.
25. Lucey DR, Novak JM, Polonis VR, Liu Y, Gartner S. Characterization of substance P binding to human monocytes/macrophages. Clin Diagn Lab Immunol. 1994;1:330 -335.
26. Wozniak A, McLennan G, Betts WH, Murphy GA, Scicchitano R. Activation of human neutrophils by substance P: effect on FMLP- stimulated oxidative and arachidonic acid metabolism and on antibody-dependent, cell mediated cytotoxicity. Immunology. 1989; 68:359-364.
27. Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D. Mast cells heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol. 1985;135:1331-1337.
28. Aliakbari J, Sreedharan SP, Turck CW, Goetzl EJ. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun. 1987;148:1440-1445.
29. Carolan EJ, Casale TB. Effects of neuropeptides on neutrophil migration through noncellular and endothelial barriers. J Allergy Clin Immunol. 1993;92:589-598.
30. Perianin A, Snyderman R, Malfroy B. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. Biochem Biophys Res Commun. 1989;161:520-524.
31. Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH. Neu-ropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocyte infiltration in human skin. J Immunol. 1993;151:3274-3282.
32. DeRose V, Robbins RA, Snider RM, et al. Substance P increases neutrophil adhesion to bronchial epithelial cells. J Immunol. 1994;152:1339 -1346.
33. Driscoll KE. Macrophages inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res. 1994;20:473-490.
34. Tran MT, Lausch RN, Oakes JE. Subsance P differentially stimulates IL-8 synthesis in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:3871-3877.
35. Harrison S, Geppetti P. Substance P. Int J Biochem Cell Biol. 2001;33:555-576.
36. Hazlett LD, McClellan SA, Rudner XL, Barrett RP. The role of Langerhans cells in Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2002;43:189 -197.
37. Collart MA, Belin D, Vasalli JD, de Kossodo S, Vassalli P. 7 Inter-feron enhances macrophage transcription of the tumor necrosis factor/calchectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med. 1986;164:2113-2118.
38. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988;241:1281-1221.
39. Delgado AV, McMannus AT, Chambers JP. Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and inter- leukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides. 2003;37:355-361.
40. Chromarat P, Rissoan MC, Banchereau J, Miossec P. Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med. 1993;177:523-527.
41. Bauerle PA, Baichwal VR. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997;65:111-137.
42. Marriott I, Mason MJ, Elhofy A, Bost KL. Substance P activates NF-κB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol. 2000;102: 163-171.
43. Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP. Ann N Y Acad Sci. 2000;921: 92-102.
44. Moody TW, Zia F, Draoui M, et al. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth. Proc Natl Acad Sci USA. 1993;90:4345-4349.